Skip to content

Keros Therapeutics, Inc.

KROS · XNAS

CIK 1664710fmd_1HPRBJZQA2STSE1RKTHBKW05ZQManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 31 periods

0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading
FinancialMD terminal